2018 Top 5 Glucagon Like Peptide-1 (GLP-1) Agonists Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

LP 2648646
123 Pages
July 2018
Pharmaceuticals

Download Sample Get Discount

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.

United States is the largest consumer of Glucagon like peptide-1 (GLP-1) agonists with the production market share of 35% and the consumption market share of 44% in 2015.

The second place is Europe, following North America with the production market share of 63% and the consumption market share of 28% in 2015.

Market competition is intense. Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi are the leader of the industry, and hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.

Over the next five years, LPI(LP Information) projects that Glucagon Like Peptide-1 (GLP-1) Agonists will register a 14.3% CAGR in terms of revenue, reach US$ 11700 million by 2023, from US$ 5240 million in 2017.

This report studies the global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:

Novo Nordisk

AstraZeneca

Eli Lilly

GSK

Sanofi

Bristol-Myers Squibb

Amylin

Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 (forecast), like

North America (United States, Canada and Mexico)

Asia-Pacific (China, Japan, Southeast Asia, India and Korea)

Europe (Germany, UK, France, Italy and Russia etc.)

South America (Brazil, Chile, Peru and Argentina)

Middle East and Africa (Egypt, South Africa, Saudi Arabia)

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into

Exenatied

Liraglutide

Lixisenatide

Albiglutide

Dulaglutide

Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into

Hospital

Pharmacy

Other

Table of Contents

2018 Top 5 Glucagon Like Peptide-1 (GLP-1) Agonists Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview

1.1 Product Overview and Scope of Glucagon Like Peptide-1 (GLP-1) Agonists

1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Types

1.2.1 Global Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Types in 2017

1.2.2 Exenatied

1.2.2.1 Major Players of Type I

1.2.3 Liraglutide

1.2.3.1 Major Players of Liraglutide

1.2.4 Lixisenatide

1.2.4.1 Major Players of Lixisenatide

1.2.5 Albiglutide

1.2.5.1 Major Players of Albiglutide

1.2.6 Dulaglutide

1.2.6.1 Major Players of Dulaglutide

1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Applications

1.3.1 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Applications in 2017

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Other

1.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market by Regions

1.4.1 North America Status and Prospect (2013-2023)

1.4.1.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2023)

1.4.2 Asia-Pacific Status and Prospect (2013-2023)

1.4.2.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2023)

1.4.3 Europe Status and Prospect (2013-2023)

1.4.3.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2023)

1.4.4 South America Status and Prospect (2013-2023)

1.4.4.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2023)

1.4.5 Middle East and Africa Status and Prospect (2013-2023)

1.4.5.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2023)

1.5 Global Market Size (Value) of Glucagon Like Peptide-1 (GLP-1) Agonists (2013-2023)

2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue (Value) and Market Share by Players

2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Players in 2016 and 2017

2.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Players in 2016 and 2017

2.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share (%) by Players in 2016 and 2017

2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Players in 2016 and 2017

2.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Players in 2016 and 2017

2.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (%) by Players in 2016 and 2017

2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Players in 2016 and 2017

2.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution, Sales Area, Product Types by Players

2.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution and Sales Area by Players

2.4.2 Players Glucagon Like Peptide-1 (GLP-1) Agonists Product Types

2.5 Glucagon Like Peptide-1 (GLP-1) Agonists Market Competitive Situation and Trends

2.5.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration Rate

2.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 3 and Top 5 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue (Value) by Regions, Type and Application (2013-2018)

3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Market Share by Regions (2013-2018)

3.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Regions (2013-2018)

3.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Regions (2013-2018)

3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Market Share and Price by Type (2013-2018)

3.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type (2013-2018)

3.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2013-2018)

3.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Application (2013-2018)

3.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

3.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

3.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

4 North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Price

4.1 North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Market Share in 2016 and 2017

4.1.1 North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share in 2016 and 2017

4.1.2 North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share in 2016 and 2017

4.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Market Share and Price by Type (2013-2018)

4.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type (2013-2018)

4.2.1.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2013-2018)

4.2.1.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

4.2.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2013-2018)

4.2.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2013-2018)

4.2.2.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

4.2.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

4.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Application (2013-2018)

4.3.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

4.3.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

4.4 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Country (US, Canada and Mexico) (2013-2018)

4.4.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2013-2018)

4.4.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

4.5 North America Glucagon Like Peptide-1 (GLP-1) Agonists Import & Export (2013-2018)

5 Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Price

5.1 Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Market Share in 2016 and 2017

5.1.1 Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share in 2016 and 2017

5.1.2 Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share in 2016 and 2017

5.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Market Share and Price by Type (2013-2018)

5.2.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type (2013-2018)

5.2.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2013-2018)

5.2.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

5.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2013-2018)

5.2.2.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2013-2018)

5.2.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

5.2.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

5.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Application (2013-2018)

5.3.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

5.3.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

5.4 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Country (Germany, UK, France, Italy and Russia) (2013-2018)

5.4.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2013-2018)

5.4.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

5.5 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Import & Export (2013-2018)

6 Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Price

6.1 Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Market Share in 2016 and 2017

6.1.1 Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share in 2016 and 2017

6.1.2 Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share in 2016 and 2017

6.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Market Share and Price by Type (2013-2018)

6.2.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type (2013-2018)

6.2.1.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2013-2018)

6.2.1.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

6.2.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2013-2018)

6.2.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

6.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Application (2013-2018)

6.3.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

6.3.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

6.4 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Country (China, Japan, Southeast Asia, India, Korea and Australia) (2013-2018)

6.4.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2013-2018)

6.4.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

6.5 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Import & Export (2013-2018)

7 South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Price

7.1 South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Market Share in 2016 and 2017

7.1.1 South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share in 2016 and 2017

7.1.2 South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share in 2016 and 2017

7.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Market Share and Price by Type (2013-2018)

7.2.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type (2013-2018)

7.2.1.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2013-2018)

7.2.1.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

7.2.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2013-2018)

7.2.2.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2013-2018)

7.2.2.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2013-2018)

7.2.3 South America Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

7.3 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Application (2013-2018)

7.3.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

7.3.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

7.4 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Country (Brazil, Argentina, Chile and Peru) (2013-2018)

7.4.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2013-2018)

7.4.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

7.5 South America Glucagon Like Peptide-1 (GLP-1) Agonists Import & Export (2013-2018)

8 Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Price

8.1 Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Market Share in 2016 and 2017

8.1.1 Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share in 2016 and 2017

8.1.2 Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share in 2016 and 2017

8.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Market Share and Price by Type (2013-2018)

8.2.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type (2013-2018)

8.2.1.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2013-2018)

8.2.1.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

8.2.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2013-2018)

8.2.2.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2013-2018)

8.2.2.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

8.2.3 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

8.3 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Application (2013-2018)

8.3.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

8.3.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

8.4 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Country (Egypt, Saudi Arabia, South Africa and Iran) (2013-2018)

8.4.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2013-2018)

8.4.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

8.5 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Import & Export (2013-2018)

9 Global Glucagon Like Peptide-1 (GLP-1) Agonists Players Profiles/Analysis

9.1 Novo Nordisk

9.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

9.1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Types, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

9.1.4 Main Business/Business Overview

9.1.5 Novo Nordisk News

9.2 AstraZeneca

9.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

9.2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Types, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

9.2.4 Main Business/Business Overview

9.2.5 AstraZeneca News

9.3 Eli Lilly

9.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

9.3.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Types, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

9.3.4 Main Business/Business Overview

9.3.5 Eli Lilly News

9.4 GSK

9.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

9.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Types, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

9.4.4 Main Business/Business Overview

9.4.5 GSK News

9.5 Sanofi

9.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

9.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Types, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

9.5.4 Main Business/Business Overview

9.5.5 Sanofi News

9.6 Bristol-Myers Squibb

9.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

9.6.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Types, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

9.6.4 Main Business/Business Overview

9.6.5 Bristol-Myers Squibb News

9.7 Amylin

9.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

9.7.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Types, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

9.7.4 Main Business/Business Overview

9.7.5 Amylin News

10 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast (2018-2023)

10.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue Forecast (2018-2023)

10.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Consumption Forecast by Regions (2018-2023)

10.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Regions (2018-2023)

10.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Regions (2018-2023)

10.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share Forecast by Type (2018-2023)

10.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Type (2018-2023)

10.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Type (2018-2023)

10.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share Forecast by Application (2018-2023)

10.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Application (2018-2023)

10.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Application (2018-2023)

10.5 Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast (2018-2023)

11 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Cost Analysis

11.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Players in 2017

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Market Effect Factors Analysis

14.1 Technology Progress/Risk

14.1.1 Substitutes Threat

14.1.2 Technology Progress in Related Industry

14.2 Consumer Needs/Customer Preference Change

14.3 Economic/Political Environmental Change

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology

16.2 Data Source

List of Tables and Figures

Figure Picture of Glucagon Like Peptide-1 (GLP-1) Agonists

Table Product Specifications of Glucagon Like Peptide-1 (GLP-1) Agonists

Figure Global Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Types in 2017

Figure Product Picture of Exenatied

Table Major Players of Exenatied

Figure Product Picture of Liraglutide

Table Major Players of Liraglutide

Figure Product Picture of Lixisenatide

Table Major Players of Lixisenatide

Figure Product Picture of Albiglutide

Table Major Players of Albiglutide

Figure Product Picture of Dulaglutide

Table Major Players of Dulaglutide

Figure Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Applications in 2017

Table Applications of Glucagon Like Peptide-1 (GLP-1) Agonists

Figure Pharmacy Examples

Figure Other Examples

Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2013-2023)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Players in 2016 and 2017

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share (%) by Players in 2016 and 2017

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Players in 2016

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Players in 2017

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Players in 2016 and 2017

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (%) by Players in 2016 and 2017

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Players in 2016

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Players in 2017

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Players in 2016 and 2017

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Players in 2017

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution and Sales Area by Players

Table Players Glucagon Like Peptide-1 (GLP-1) Agonists Product Types

Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 3 Players

Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 5 Players

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Regions (2013-2018)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Regions (2013-2018)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Regions (2013-2018)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Regions in 2017

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Regions (2013-2018)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Regions (2013-2018)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Regions (2013-2018)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Regions in 2017

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2013-2018)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2017

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2013-2018)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type in 2017

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2017

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

Table North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales in 2016 and 2017

Table North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share (%) in 2016 and 2017

Figure North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share in 2016

Figure North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share in 2017

Table North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2016 and 2017

Table North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (%) in 2016 and 2017

Figure North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share in 2016

Figure North America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share in 2017

Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2013-2018)

Figure 2017 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type

Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2013-2018)

Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type in 2017

Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application in 2017

Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2013-2018)

Figure 2017 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country

Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

Table North America Glucagon Like Peptide-1 (GLP-1) Agonists Import & Export (2013-2018)

Table Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales in 2016 and 2017

Table Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share (%) in 2016 and 2017

Figure Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share in 2016

Figure Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share in 2017

Table Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2016 and 2017

Table Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (%) in 2016 and 2017

Figure Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share in 2016

Figure Europe Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share in 2017

Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2013-2018)

Figure 2017 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type

Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2013-2018)

Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type in 2017

Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2017

Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2013-2018)

Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country in 2017

Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Import & Export (2013-2018)

Table Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales in 2016 and 2017

Table Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share (%) in 2016 and 2017

Figure Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share in 2016

Figure Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share in 2017

Table Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2016 and 2017

Table Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (%) in 2016 and 2017

Figure Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share in 2016

Figure Asia-Pacific Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share in 2017

Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2013-2018)

Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2017

Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2013-2018)

Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type in 2017

Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application in 2017

Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2013-2018)

Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country in 2017

Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

Figure Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

Table Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Import & Export (2013-2018)

Table South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales in 2016 and 2017

Table South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share (%) in 2016 and 2017

Figure South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share in 2016

Figure South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share in 2017

Table South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2016 and 2017

Table South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (%) in 2016 and 2017

Figure South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share in 2016

Figure South America Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share in 2017

Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2013-2018)

Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type in 2017

Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2013-2018)

Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type in 2017

Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application in 2017

Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2013-2018)

Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country in 2017

Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

Figure South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

Table South America Glucagon Like Peptide-1 (GLP-1) Agonists Import & Export (2013-2018)

Table Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales in 2016 and 2017

Table Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share (%) in 2016 and 2017

Figure Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share in 2016

Figure Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share in 2017

Table Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2016 and 2017

Table Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (%) in 2016 and 2017

Figure Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share in 2016

Figure Middle East & Africa Top 5 Players Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share in 2017

Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2013-2018)

Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type in 2017

Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2013-2018)

Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2013-2018)

Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type in 2017

Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2013-2018)

Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2013-2018)

Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2013-2018)

Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application in 2017

Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2013-2018)

Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2013-2018)

Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country in 2017

Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2013-2018)

Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Import & Export (2013-2018)

Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2013-2018)

Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2013-2018)

Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

Figure Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2013-2018)

Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2013-2018)

Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2013-2018)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2013-2018)

Table Amylin Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2013-2018)

Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2013-2018)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate Forecast (2018-2023)

Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate Forecast (2018-2023)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Regions (2018-2023)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Regions (2018-2023)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Type (2018-2023)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Type (2018-2023)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Application (2018-2023)

Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Application (2018-2023)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Glucagon Like Peptide-1 (GLP-1) Agonists

Table Major Buyers of Glucagon Like Peptide-1 (GLP-1) Agonists

Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis

Table Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Players in 2017

Table Major Buyers of Glucagon Like Peptide-1 (GLP-1) Agonists

Table Distributors/Traders List

Purchase Options

Single User License $4960 Multiple $7440 Corporate $9920

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

Publish Date: November 14, 2017
$5370

View Details

Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

Publish Date: July 20, 2017
$5370

View Details

Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

Publish Date: April 24, 2017
$5370

View Details

Client Testimonials

Your team has worked hard to help and to provide our research needs to fulfill our significant initiatives...

Maria

-Researcher

The report on EAA resins was detailed and informative. However, we were hopeful to discover a Chinese producer ...

David

-President Protech Oxyplast Group

Thanks the attached report is perfect and accurate, but I was wondering if you can show the price trend in one year...

2018 Top 5 Glucagon Like Peptide-1 (GLP-1) Agonists Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara